Harmony Biosciences (HRMY) Short Interest Ratio & Short Volume $34.28 +0.39 (+1.15%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Harmony Biosciences Short Interest DataHarmony Biosciences (HRMY) has a short interest of 5.45 million shares, representing 13.46% of the float (the number of shares available for trading by the public). This marks a -6.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 487,868 shares to cover all short positions.Current Short Interest5,450,000 sharesPrevious Short Interest5,800,000 sharesChange Vs. Previous Month-6.03%Dollar Volume Sold Short$188.95 millionShort Interest Ratio7.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares57,031,000 sharesFloat Size40,490,000 sharesShort Percent of Float13.46%Today's Trading Volume2,976,575 sharesAverage Trading Volume487,868 sharesToday's Volume Vs. Average610% Short Selling Harmony Biosciences? Sign up to receive the latest short interest report for Harmony Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHRMY Short Interest Over TimeHRMY Days to Cover Over TimeHRMY Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Harmony Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20245,450,000 shares $188.95 million -6.0%13.5%7.3 $34.67 11/15/20245,800,000 shares $192.65 million -4.3%14.3%8 $33.22 10/31/20246,060,000 shares $194.71 million -18.7%15.2%8.9 $32.13 10/15/20247,450,000 shares $264.48 million -12.8%24.3%16.9 $35.50 9/30/20248,540,000 shares $341.60 million +1.6%27.8%19.8 $40.00 9/15/20248,410,000 shares $327.23 million -4.0%27.4%21.4 $38.91 Get the Latest News and Ratings for HRMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harmony Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/20248,760,000 shares $315.18 million +0.3%28.6%23.5 $35.98 8/15/20248,730,000 shares $307.73 million +3.9%28.5%24 $35.25 7/31/20248,400,000 shares $284.42 million +4.2%27.4%22.4 $33.86 7/15/20248,060,000 shares $274.12 million -3.1%26.3%20 $34.01 6/30/20248,320,000 shares $251.01 million +2.3%27.2%20.4 $30.17 6/15/20248,130,000 shares $236.18 million +17.2%26.5%21.2 $29.05 5/31/20246,940,000 shares $204.04 million -2.1%22.7%17.4 $29.40 5/15/20247,090,000 shares $210.57 million +5.5%23.1%17.1 $29.70 4/30/20246,720,000 shares $207.72 million +4.0%16.1%15.9 $30.91 4/15/20246,460,000 shares $190.70 million +1.7%21.0%17.6 $29.52 3/31/20246,350,000 shares $213.23 million +4.3%20.7%17.5 $33.58 3/15/20246,090,000 shares $194.76 million -3.2%19.8%16.9 $31.98 2/29/20246,290,000 shares $201.91 million -1.9%19.9%15.4 $32.10 2/15/20246,410,000 shares $224.73 million +0.9%20.3%15.1 $35.06 1/31/20246,350,000 shares $200.28 million +1.6%19.5%13.8 $31.54 1/15/20246,250,000 shares $195.75 million +3.5%19.2%10.7 $31.32 12/31/20236,040,000 shares $195.09 million +2.4%18.6%8 $32.30 12/15/20235,900,000 shares $198.65 million -0.8%18.1%7.8 $33.67 11/30/20235,950,000 shares $172.91 million +0.3%17.9%7.6 $29.06 11/15/20235,930,000 shares $149.44 million +11.1%17.9%7.4 $25.20 10/31/20235,340,000 shares $125.70 million -22.6%16.1%6.8 $23.54 10/15/20236,900,000 shares $145.66 million -1.6%20.3%9.4 $21.11 9/30/20237,010,000 shares $229.72 million -4.6%20.6%12.4 $32.77 9/15/20237,350,000 shares $275.77 million -5.0%21.6%13.8 $37.52 8/31/20237,740,000 shares $280.58 million +3.8%22.8%15.7 $36.25 8/15/20237,460,000 shares $245.36 million -2.1%22.0%16.6 $32.89 7/31/20237,620,000 shares $269.52 million -8.5%22.6%16.7 $35.37 7/15/20238,330,000 shares $294.47 million -1.2%24.7%16.7 $35.35 6/30/20238,430,000 shares $296.65 million +2.9%25.0%15.7 $35.19 6/15/20238,190,000 shares $297.05 million +2.1%24.3%9.6 $36.27 5/31/20238,020,000 shares $277.33 million +0.6%23.9%9.2 $34.58 5/15/20237,970,000 shares $291.22 million -2.3%23.8%8.5 $36.54 4/30/20238,160,000 shares $263.08 million +2.1%24.4%8.6 $32.24 4/15/20237,990,000 shares $251.76 million +7.0%24.1%8.9 $31.51URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 3/31/20237,470,000 shares $243.90 million +19.0%22.6%8 $32.65 3/15/20236,280,000 shares $255.22 million +8.3%19.0%10.6 $40.64 2/28/20235,800,000 shares $255.37 million +8.0%17.5%10.5 $44.03 2/15/20235,370,000 shares $262.16 million +5.5%16.3%10.2 $48.82 1/31/20235,090,000 shares $245.19 million -3.8%15.5%10.7 $48.17 1/15/20235,290,000 shares $250.85 million +21.1%16.2%10.5 $47.42 12/30/20224,370,000 shares $240.79 million +9.3%13.3%8.9 $55.10 12/15/20224,000,000 shares $224.52 million -26.1%12.5%8.8 $56.13 11/30/20225,410,000 shares $323.36 million -4.6%17.0%10.9 $59.77 11/15/20225,670,000 shares $318.09 million -1.7%17.8%11.5 $56.10 10/31/20225,770,000 shares $300.04 million +0.2%18.5%11.3 $52.00 10/15/20225,760,000 shares $294.16 million -5.0%18.5%10.8 $51.07 9/30/20226,060,000 shares $268.40 million +5.6%19.5%11.2 $44.29 9/15/20225,740,000 shares $257.96 million +9.5%18.5%10.1 $44.94 8/31/20225,240,000 shares $230.09 million +2.8%16.9%9.6 $43.91 8/15/20225,100,000 shares $259.59 million +3.0%16.4%9.4 $50.90 7/31/20224,950,000 shares $251.11 million +5.8%16.6%9.2 $50.73 7/15/20224,680,000 shares $251.08 million +6.6%15.7%8.9 $53.65 6/30/20224,390,000 shares $214.10 million +6.3%14.8%8.2 $48.77 6/15/20224,130,000 shares $184.24 million +2.0%14.1%7.9 $44.61 5/31/20224,050,000 shares $176.58 million +1.0%13.8%7.7 $43.60 5/15/20224,010,000 shares $152.30 million +2.6%13.7%7.4 $37.98 4/30/20223,910,000 shares $176.11 million +3.7%14.1%7.6 $45.04 4/15/20223,770,000 shares $194.31 million +3.6%13.7%8.4 $51.54 3/31/20223,640,000 shares $177.09 million +1.4%N/A9.3 $48.65 3/15/20223,590,000 shares $157.31 million +7.2%13.7%9.4 $43.82 2/28/20223,350,000 shares $133.87 million +2.1%12.7%9.3 $39.96 2/15/20223,280,000 shares $130.38 million +10.8%12.6%10.4 $39.75 1/31/20222,960,000 shares $106.15 million -10.0%14.1%9 $35.86 1/15/20223,290,000 shares $120.68 million +10.8%N/A0 $36.68 12/31/20212,970,000 shares $126.64 million -2.9%12.0%6.1 $42.64 12/15/20213,060,000 shares $120.50 million -5.0%12.4%6.4 $39.38 11/30/20213,220,000 shares $109.77 million +22.0%12.9%6.2 $34.09 11/15/20212,640,000 shares $108.27 million +3.5%10.6%5 $41.01 10/29/20212,550,000 shares $105.75 million +94.7%11.6%4.8 $41.47 10/15/20211,310,000 shares $51.61 million -7.1%6.0%2.6 $39.40 9/30/20211,410,000 shares $54.05 million +52.1%6.4%4 $38.33 9/15/2021927,100 shares $33.70 million -4.9%4.1%2.6 $36.35 8/31/2021974,500 shares $33.03 million -10.6%4.3%3.4 $33.89 8/13/20211,090,000 shares $35.04 million +2.8%4.8%3.9 $32.15 7/30/20211,060,000 shares $27.73 million +16.6%4.9%3.7 $26.16 7/15/2021908,800 shares $26.36 million -1.2%4.2%3.4 $29.01 6/30/2021919,700 shares $25.96 million +53.9%4.2%3.7 $28.23 6/15/2021597,700 shares $18.97 million -6.3%2.8%2.9 $31.73 5/28/2021638,000 shares $20.39 million +7.7%2.9%3 $31.96 5/14/2021592,500 shares $15.46 million +20.3%2.9%3.2 $26.10 4/30/2021492,500 shares $14.29 million +61.9%1.7%3.5 $29.01 4/15/2021304,300 shares $8.85 million -54.1%1.1%2.4 $29.08 3/31/2021663,200 shares $21.24 million +7.5%3.2%5.3 $32.03 3/15/2021617,200 shares $18.84 million +5.6%3.0%4.9 $30.52URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 2/26/2021584,500 shares $21.15 million +23.4%2.9%4.9 $36.18 2/12/2021473,800 shares $18.16 million -3.4%2.3%3.6 $38.33 1/29/2021490,400 shares $17.51 million -27.2%2.4%3.3 $35.71 1/15/2021673,900 shares $26.02 million No Change3.3%4.2 $38.61 HRMY Short Interest - Frequently Asked Questions What is Harmony Biosciences' current short interest? Short interest is the volume of Harmony Biosciences shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 5,450,000 shares of HRMY short. 13.46% of Harmony Biosciences' shares are currently sold short. Learn More on Harmony Biosciences' current short interest. What is a good short interest ratio for Harmony Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HRMY shares currently have a short interest ratio of 7.0. Learn More on Harmony Biosciences's short interest ratio. Which institutional investors are shorting Harmony Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Harmony Biosciences: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Harmony Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.46% of Harmony Biosciences' floating shares are currently sold short. Is Harmony Biosciences' short interest increasing or decreasing? Harmony Biosciences saw a drop in short interest in November. As of November 30th, there was short interest totaling 5,450,000 shares, a drop of 6.0% from the previous total of 5,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Harmony Biosciences' float size? Harmony Biosciences currently has issued a total of 57,031,000 shares. Some of Harmony Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harmony Biosciences currently has a public float of 40,490,000 shares. How does Harmony Biosciences' short interest compare to its competitors? 13.46% of Harmony Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Harmony Biosciences: Lantheus Holdings, Inc. (6.73%), Nuvalent, Inc. (12.26%), Legend Biotech Co. (13.04%), Blueprint Medicines Co. (6.60%), Elanco Animal Health Incorporated (3.15%), Cytokinetics, Incorporated (12.35%), TG Therapeutics, Inc. (20.71%), Viking Therapeutics, Inc. (16.22%), BridgeBio Pharma, Inc. (11.52%), Crinetics Pharmaceuticals, Inc. (6.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Harmony Biosciences stock? Short selling HRMY is an investing strategy that aims to generate trading profit from Harmony Biosciences as its price is falling. HRMY shares are trading up $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harmony Biosciences? A short squeeze for Harmony Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HRMY, which in turn drives the price of the stock up even further. How often is Harmony Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRMY, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Lantheus Short Interest Nuvalent Short Interest Legend Biotech Short Interest Blueprint Medicines Short Interest Elanco Animal Health Short Interest Cytokinetics Short Interest TG Therapeutics Short Interest Viking Therapeutics Short Interest BridgeBio Pharma Short Interest Crinetics Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HRMY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRMY Stock Alerts